Personalized treatment study for head and neck cancer
Part of Cancer clinical trials.
This study looks at the genetic information in your tumor to find new ways to treat head and neck cancer. You'll get extra biopsies and blood tests, and your genetic data will be shared with researchers to help personalize future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have head and neck cancer (like mouth, throat, or voice box) or nasopharyngeal cancer that is locally advanced, meaning it hasn't spread far.
- You are planning to have radiation therapy (with or without chemotherapy) with the goal of curing the cancer.
- You are willing to have extra tissue samples (biopsies) taken from your tumor and give blood for genetic testing.
- You are 18 years old or older.
- You have not had chemotherapy or radiation within the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study looks at “circulating tumor DNA” (tumor DNA found in blood) in people with newly diagnosed, locally advanced head and neck squamous cell cancer. Researchers want to see how the blood DNA levels relate to the cancer and how it may guide treatment after surgery.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.